Venus Concept is a global medical technology company that develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Co.'s products include: Venus Legacy, in which the Venus Legacy BX is a noninvasive device intended for use in dermatological and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick Skin Types I-IV; Venus Versa, in which the Venus Versa system is a multi-application device intended for use in aesthetic and cosmetic procedures; and Venus Glow, in which Venus Glow is a motorized dermabrasion device. We show 14 historical shares outstanding datapoints in our coverage of VERO's shares outstanding history.
Understanding the changing numbers of VERO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like VERO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching VERO by allowing them to research VERO shares outstanding history
as well as any other stock in our coverage universe. |
Free VERO Email Alerts:
Video: Shares Outstanding Importance
